RadNet, Inc. (RDNT) stock
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3054% above fair value
$71.82−3.10 (-4.14%)
Close on Nov 18, 2026Market cap $5.65BP/E –Yield –
RadNet revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
RadNet's revenue for the twelve months ending Jun 30, 2026 was $2.27B, up 18.9% year over year. For fiscal 2025 it was $2.04B, up 11.5% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $2.04B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.04B | +11.5% |
| FY2024 | Dec 31, 2024 | $1.83B | +13.2% |
| FY2023 | Dec 31, 2023 | $1.62B | +13.0% |
| FY2022 | Dec 31, 2022 | $1.43B | +8.7% |
| FY2021 | Dec 31, 2021 | $1.32B | +22.7% |
| FY2020 | Dec 31, 2020 | $1.07B | -7.1% |
| FY2019 | Dec 31, 2019 | $1.15B | +18.4% |
| FY2018 | Dec 31, 2018 | $975.15M | +5.7% |
| FY2017 | Dec 31, 2017 | $922.19M | +4.3% |
| FY2016 | Dec 31, 2016 | $884.54M | +9.3% |
| FY2015 | Dec 31, 2015 | $809.63M | +12.8% |
| FY2014 | Dec 31, 2014 | $717.57M | +2.1% |
| FY2013 | Dec 31, 2013 | $702.99M | +8.6% |
| FY2012 | Dec 31, 2012 | $647.15M | +10.6% |
| FY2011 | Dec 31, 2011 | $585.12M | +660.5% |
| FY2010 | Dec 31, 2010 | $76.94M | -85.4% |
| FY2009 | Dec 31, 2009 | $527.62M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $622.72M | +25.0% |
| Q1 FY2026 | Mar 31, 2026 | $575.63M | +22.1% |
| Q4 FY2025 | Dec 31, 2025 | $547.71M | +14.8% |
| Q3 FY2025 | Sep 30, 2025 | $522.87M | +13.4% |
| Q2 FY2025 | Jun 30, 2025 | $498.23M | +8.4% |
| Q1 FY2025 | Mar 31, 2025 | $471.40M | +9.2% |
| Q4 FY2024 | Dec 31, 2024 | $477.10M | +13.5% |
| Q3 FY2024 | Sep 30, 2024 | $461.14M | +14.7% |
| Q2 FY2024 | Jun 30, 2024 | $459.71M | +13.9% |
| Q1 FY2024 | Mar 31, 2024 | $431.71M | +10.5% |
| Q4 FY2023 | Dec 31, 2023 | $420.38M | +9.5% |
| Q3 FY2023 | Sep 30, 2023 | $401.97M | +14.8% |
| Q2 FY2023 | Jun 30, 2023 | $403.72M | +13.9% |
| Q1 FY2023 | Mar 31, 2023 | $390.56M | +14.3% |
| Q4 FY2022 | Dec 31, 2022 | $383.88M | +15.2% |
| Q3 FY2022 | Sep 30, 2022 | $350.04M | +5.2% |
| Q2 FY2022 | Jun 30, 2022 | $354.38M | +6.1% |
| Q1 FY2022 | Mar 31, 2022 | $341.77M | +8.4% |
| Q4 FY2021 | Dec 31, 2021 | $333.15M | +8.2% |
| Q3 FY2021 | Sep 30, 2021 | $332.69M | +14.0% |
| Q2 FY2021 | Jun 30, 2021 | $333.92M | +75.2% |
| Q1 FY2021 | Mar 31, 2021 | $315.32M | +12.0% |
| Q4 FY2020 | Dec 31, 2020 | $307.94M | +2.4% |
| Q3 FY2020 | Sep 30, 2020 | $291.78M | -0.3% |
| Q2 FY2020 | Jun 30, 2020 | $190.57M | -34.1% |
| Q1 FY2020 | Mar 31, 2020 | $281.56M | +3.7% |
| Q4 FY2019 | Dec 31, 2019 | $300.84M | +17.0% |
| Q3 FY2019 | Sep 30, 2019 | $292.69M | +20.9% |
| Q2 FY2019 | Jun 30, 2019 | $289.10M | +18.3% |
| Q1 FY2019 | Mar 31, 2019 | $271.55M | +17.4% |
| Q4 FY2018 | Dec 31, 2018 | $257.21M | +9.2% |
| Q3 FY2018 | Sep 30, 2018 | $242.15M | +6.4% |
| Q2 FY2018 | Jun 30, 2018 | $244.40M | +6.3% |
| Q1 FY2018 | Mar 31, 2018 | $231.39M | +1.0% |
| Q4 FY2017 | Dec 31, 2017 | $235.55M | +4.7% |
| Q3 FY2017 | Sep 30, 2017 | $227.61M | +1.3% |
| Q2 FY2017 | Jun 30, 2017 | $230.01M | – |
| Q1 FY2017 | Mar 31, 2017 | $229.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $224.94M | – |
| Q3 FY2016 | Sep 30, 2016 | $224.64M | – |
See a number that looks wrong?